GLOBUS MEDICAL INC
Globus Medical, Inc. (NASDAQ: GLMD) is a medical device company headquartered in Audubon, Pennsylvania that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Founded in 2003, the company operates globally across 65 countries and manages its business within one reportable… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What GLOBUS MEDICAL INC does
In the company’s own words
Globus Medical, Inc. (NASDAQ: GLMD) is a medical device company headquartered in Audubon, Pennsylvania that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Founded in 2003, the company operates globally across 65 countries and manages its business within one reportable segment while organizing products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies.
The Musculoskeletal Solutions portfolio comprises implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation therapy, and neuromonitoring services used across spinal, orthopedic, and neurosurgical procedures. This segment includes comprehensive spine products addressing degenerative conditions, deformity, tumors, and trauma; orthopedic trauma solutions spanning limb reconstruction, fracture plating, and intramedullary nailing anchored by the PRECICE limb reconstruction platform; hip and knee arthroplasty systems; and the HFX spinal cord stimulation platform acquired through the Nevro merger for chronic pain treatment. The Enabling Technologies category encompasses imaging, navigation, and robotics solutions including the ExcelsiusGPS robotic guidance system, Surgimap surgical planning software, and the ExcelsiusXR extended reality navigation headset launched in 2025.
During 2025, Globus launched nine new products and completed the acquisition of Nevro Corp, a leader in spinal cord stimulation technology. The company previously acquired NuVasive in 2023, significantly expanding its spine technology portfolio and commercial reach. International sales represented approximately 19.4 percent of total revenue during 2025, with the company maintaining direct and distributor sales presence across 64 countries outside the United States.
Globus manufactures implant products at facilities in Eagleville and Limerick, Pennsylvania, and West Carrollton, Ohio, with robotic systems assembled in Methuen, Massachusetts and spinal cord stimulation products manufactured in Costa Rica. The company employs an integrated product development approach involving surgeons, engineers, researchers, and machinists supported by in-house research capabilities including mechanical testing, biomechanical, and cadaveric laboratories. As of December 31, 2025, Globus held 3,374 issued U.S. patents and 2,311 issued foreign patents, with a trademark portfolio containing 984 registered trademarks.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- AUDUBON, PA
- Fiscal year end
- December
- CIK
- 1237831
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns GLOBUS MEDICAL INC — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in GLOBUS MEDICAL INC · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · GLOBUS MEDICAL INC’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do GLOBUS MEDICAL INC and its peers compare on margins and cash generation over ten years?”
- “Where did five years of GLOBUS MEDICAL INC's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in GLOBUS MEDICAL INC's last four quarterly filings that the numbers alone won't show?”